Generics' value share of Japan's market edges past 9%
This article was originally published in Scrip
Executive Summary
Helped by a series of government incentives over the past few years and the expiry of several major patents, the share of Japan's prescription drug market held by generics passed the 9% mark in value terms in the fiscal year ended 31 March.